Rabies Vaccine (Human use) 0.5mL/1mLInactivated Rabies Vaccine (Human use)(0.5ml/1ml). Each dose 0.1ml to contain at least 7 IU/ml of rabies Antigen as an inactivated freeze-dried powder form. Each vial should be either 0.5mL or 1mL. The Vaccine shou

• Country: Sri Lanka
• Summary: Rabies Vaccine (Human use) 0.5mL/1mLInactivated Rabies Vaccine (Human use)(0.5ml/1ml). Each dose 0.1ml to contain at least 7 IU/ml of rabies Antigen as an inactivated freeze-dried powder form. Each vial should be either 0.5mL or 1mL. The Vaccine shou
• LKT Ref No: 120782001
• Deadline: 30 Jun 2025
• Financier: Self Financed
• Purchaser Ownership: Public
• Tender Value: Refer Document
• Notice Type: Tender
• Document Ref. No.: DHS/RP/99/2025
• Purchaser's Detail:

Purchaser : STATE PHARMACEUTICALS CORPORATION OF SRI LANKA
No.75, Sir Baron Jayathilake Mawatha, Colombo 01, Sri Lanka. Telephone :+94 (0)11 2320356-9, Fax :+94 (0)11 2447118
Email :chairman@spc.lk

• Description:
• Rabies Vaccine (Human use) 0.5mL/1mLInactivated Rabies Vaccine (Human use)(0.5ml/1ml). Each dose 0.1ml to contain at least 7 IU/ml of rabies Antigen as an inactivated freeze-dried powder form. Each vial should be either 0.5mL or 1mL. The Vaccine should be suitable for human use, produced in cell culture.(Eg. Primary chickembryo cell culture Rabies Vaccine, Vero cell Rabies Vaccine). The vaccine should comply with the Rabies Vaccine as the Pharmacopoeial requirement of Vaccine and biological products.
• Documents:

 Tender Notice